Terms: = Kidney tumors AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Clinical Outcome
9 results:
1. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
[TBL] [Abstract] [Full Text] [Related]
2. A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma.
Wu S; Li X
Bioengineered; 2021 Dec; 12(1):1642-1662. PubMed ID: 33955826
[TBL] [Abstract] [Full Text] [Related]
3. Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS.
Wang KJ; Meng XY; Chen JF; Wang KY; Zhou C; Yu R; Ma Q
Oxid Med Cell Longev; 2021; 2021():8840590. PubMed ID: 33532038
[TBL] [Abstract] [Full Text] [Related]
4. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract] [Full Text] [Related]
5. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
6. clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.
Chuang CK; Lin HCA; Tasi HY; Lee KH; Kao Y; Chuang FL; Chang YH; Lin PH; Liu CY; Pang ST
Int Urol Nephrol; 2017 Sep; 49(9):1527-1536. PubMed ID: 28547571
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of miR-19a exhibits inhibitory effects on metastatic renal cell carcinoma by targeting pik3ca and inactivating Notch signaling in vitro.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
Oncol Rep; 2015 Aug; 34(2):739-46. PubMed ID: 26058752
[TBL] [Abstract] [Full Text] [Related]
8. Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARĪ³-targeted therapy.
Jagan I; Fatehullah A; Deevi RK; Bingham V; Campbell FC
Oncogene; 2013 Mar; 32(10):1305-15. PubMed ID: 22543585
[TBL] [Abstract] [Full Text] [Related]
9. Activation of pi3k is associated with reduced survival in renal cell carcinoma.
Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
[TBL] [Abstract] [Full Text] [Related]
